how do i switch from semaglutide to tirzepatide Switching Tirzepatide: What to Expect — Affinity Whole Health Switch from Semaglutide to Tirzepatide
Description
Semaglutide is not contraindicated in inflammatory bowel disease, but patients with ulcerative colitis or Crohn's disease should discuss their condition with their healthcare provider before starting treatment

However, nausea itself is not necessary for weight lossmany patients experience minimal nausea while still achieving excellent results, especially with slower dose escalation

So how do we, on a daily basis, boost our GLP-1, maintain our weight, maintain our glycemic index and more

Dr Formichi was supported by 2268-2022-FC-CONRICMIUR_PC-FCUR2022_001 grant

The combination produced a mean weight reduction of 20.4% under the treatment-policy estimand, versus 3.0% with placebo (-17.3% difference
